SCHEMBL6710591

SCHEMBL6710591

COc1ccc(NC(=O)Nc2ccc(OC(c3ccccc3)c3ccc(F)c(F)c3)c(C(=O)O)c2)cc1OC

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 8/20 0.50
MEN1 O00255 7/20 0.50
ALDH1A1 P00352 4/20 0.50
RAB9A P51151 4/20 0.48
LMNA P02545 2/20 0.47
SMN1; SMN2 Q16637 2/20 0.45
NPC1 O15118 2/20 0.45
MAPT P10636 8/20 0.44
KDM4E B2RXH2 4/20 0.44
HSD17B10 Q99714 2/20 0.44
HPGD P15428 1/20 0.44
NPSR1 Q6W5P4 1/20 0.44
RCE1 Q9Y256 1/20 0.44
FPR2 P25090 1/20 0.44
GAA P10253 2/20 0.43
MAPK1 P28482 2/20 0.43
CTSV O60911 1/20 0.43
CTSL P07711 1/20 0.43
TP53 P04637 1/20 0.43
ALOX15 P16050 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6564577 0.93 KMT2A (0.49) KMT2AMEN1ALDH1A1RAB9ALMNA
SCHEMBL6711898 0.91 KMT2A (0.49) KMT2AMEN1ALDH1A1RAB9ALMNA
SCHEMBL6564812 0.88 RAB9A (0.48) KMT2AMEN1ALDH1A1RAB9ALMNA
SCHEMBL6565985 0.87 MAPT (0.46) KMT2AMEN1ALDH1A1RAB9ALMNA
SCHEMBL6567726 0.87 MAPT (0.51) KMT2AMEN1ALDH1A1RAB9ALMNA
SCHEMBL6566938 0.86 MEN1 (0.47) KMT2AMEN1ALDH1A1RAB9ALMNA
SCHEMBL6566753 0.85 RAB9A (0.47) KMT2AMEN1RAB9ALMNASMN1; SMN2
SCHEMBL6566004 0.85 RAB9A (0.47) KMT2AMEN1ALDH1A1RAB9ALMNA
SCHEMBL6565683 0.84 KMT2A (0.50) KMT2AMEN1ALDH1A1RAB9ALMNA
SCHEMBL6566020 0.83 MEN1 (0.53) KMT2AMEN1ALDH1A1RAB9ALMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040259912-A1 Benzine derivatives, process for preparing the same and use thereof TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2004-12-23 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040259912-A1 Benzine derivatives, process for preparing the same and use thereof HRH4, HRH2, HRH1 KMT2A 3137/4885MEN1 4143/4885ALDH1A1 907/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.